
Sign up to save your podcasts
Or


Hi, I am Marmee Regine, your host in Pandemic Podcast Coronavirus. The special episode is from Vejon health with 16.5K subscribers. The title of this interview is about mass vaccination in a pandemic as the benefits versus the risks are discussed as we listen to the interview with Dr. Geert Vanden Bossche by Dr. Philip McMillan. Who is Dr. Bossche? He is an international vaccine expert, previous head of vaccine development in Germany and the chief scientific officer in Univac. The reason I wanted to share this interview was since its publication last March 6, 2021, it gained 1,263,274 views. Plus, we wanted to hear his expert opinions on mass vaccination. Vejon Health 16.5K subscribers Highlighting the principle of using a prophylactic vaccine in the midst of a pandemic. Likely to create more viral variants in the process. Timecodes: 0:00 - Intro 7:36 - Lockdowns 8:51 - Gaining immunity from exposure & immunological escape 11:17 - COVID vaccine 18:30 - COVID antibodies 19:55 - NK Cells 25:00 - Antigen-specific antibodies outcompete natural antibodies 28:51 - Highly-infectious strain 31:01 - Vaccine resistance in COVID pandemic 31:51 - More on immunological escape 32:59 - Geert Vanden Bossche’s thoughts on COVID vaccination Geert Vanden Bossche Ph.D., is an internationally recognized vaccine developer having worked as the head of the Vaccine Development Office at the German Centre for Infection Research. Coordinated Global Alliance for Vaccines and Immunization’s Ebola Vaccine Program and contributed to the implementation of an integrated vaccine work plan in collaboration with Global Health Partners (WHO, Bill & Melinda Gates Foundation, CDC, UNICEF), regulators (FDA), and vaccine manufacturers to enable timely deployment or stockpiling of Ebola vaccine candidates. We are sharing his perspective on mass vaccination in COVID-19. That’s all for this episode and you can support Vejon Health with a financial contribution through the Patreon page. Access other posts, podcasts & videos of Dr. Philip McMillan - https://patreon.com/VejonHealth Learn more about autoimmunity in COVID-19. - https://mcmillanresearch.com/There you go, friends. Until the next special episode on another interview with Dr. Geert Vanden Bossche if mass vaccination should stop. I am Marmee Regine, your host in P
Support the show (https://www.patreon.com/pandemicpodcastcoronavirus)
By Marmee Regine CosicoHi, I am Marmee Regine, your host in Pandemic Podcast Coronavirus. The special episode is from Vejon health with 16.5K subscribers. The title of this interview is about mass vaccination in a pandemic as the benefits versus the risks are discussed as we listen to the interview with Dr. Geert Vanden Bossche by Dr. Philip McMillan. Who is Dr. Bossche? He is an international vaccine expert, previous head of vaccine development in Germany and the chief scientific officer in Univac. The reason I wanted to share this interview was since its publication last March 6, 2021, it gained 1,263,274 views. Plus, we wanted to hear his expert opinions on mass vaccination. Vejon Health 16.5K subscribers Highlighting the principle of using a prophylactic vaccine in the midst of a pandemic. Likely to create more viral variants in the process. Timecodes: 0:00 - Intro 7:36 - Lockdowns 8:51 - Gaining immunity from exposure & immunological escape 11:17 - COVID vaccine 18:30 - COVID antibodies 19:55 - NK Cells 25:00 - Antigen-specific antibodies outcompete natural antibodies 28:51 - Highly-infectious strain 31:01 - Vaccine resistance in COVID pandemic 31:51 - More on immunological escape 32:59 - Geert Vanden Bossche’s thoughts on COVID vaccination Geert Vanden Bossche Ph.D., is an internationally recognized vaccine developer having worked as the head of the Vaccine Development Office at the German Centre for Infection Research. Coordinated Global Alliance for Vaccines and Immunization’s Ebola Vaccine Program and contributed to the implementation of an integrated vaccine work plan in collaboration with Global Health Partners (WHO, Bill & Melinda Gates Foundation, CDC, UNICEF), regulators (FDA), and vaccine manufacturers to enable timely deployment or stockpiling of Ebola vaccine candidates. We are sharing his perspective on mass vaccination in COVID-19. That’s all for this episode and you can support Vejon Health with a financial contribution through the Patreon page. Access other posts, podcasts & videos of Dr. Philip McMillan - https://patreon.com/VejonHealth Learn more about autoimmunity in COVID-19. - https://mcmillanresearch.com/There you go, friends. Until the next special episode on another interview with Dr. Geert Vanden Bossche if mass vaccination should stop. I am Marmee Regine, your host in P
Support the show (https://www.patreon.com/pandemicpodcastcoronavirus)